These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28838672)

  • 1. Omics of Prion Diseases.
    Vanni S
    Prog Mol Biol Transl Sci; 2017; 150():409-431. PubMed ID: 28838672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases.
    Sun YV; Hu YJ
    Adv Genet; 2016; 93():147-90. PubMed ID: 26915271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proteomics in understanding prion infection.
    Campisi E; Cardone F; Graziano S; Galeno R; Pocchiari M
    Expert Rev Proteomics; 2012 Dec; 9(6):649-66. PubMed ID: 23256675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a Taxonomy for Multi-Omics Science? Terminology Development for Whole Genome Study Approaches by Omics Technology and Hierarchy.
    Pirih N; Kunej T
    OMICS; 2017 Jan; 21(1):1-16. PubMed ID: 28271979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic responses to prion disease in rats.
    Herbst A; Ness A; Johnson CJ; McKenzie D; Aiken JM
    BMC Genomics; 2015 Sep; 16(1):682. PubMed ID: 26341492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-omic analysis of human naïve CD4+ T cells.
    Mitchell CJ; Getnet D; Kim MS; Manda SS; Kumar P; Huang TC; Pinto SM; Nirujogi RS; Iwasaki M; Shaw PG; Wu X; Zhong J; Chaerkady R; Marimuthu A; Muthusamy B; Sahasrabuddhe NA; Raju R; Bowman C; Danilova L; Cutler J; Kelkar DS; Drake CG; Prasad TS; Marchionni L; Murakami PN; Scott AF; Shi L; Thierry-Mieg J; Thierry-Mieg D; Irizarry R; Cope L; Ishihama Y; Wang C; Gowda H; Pandey A
    BMC Syst Biol; 2015 Nov; 9():75. PubMed ID: 26542228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease.
    Dumitriu A; Golji J; Labadorf AT; Gao B; Beach TG; Myers RH; Longo KA; Latourelle JC
    BMC Med Genomics; 2016 Jan; 9():5. PubMed ID: 26793951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics applications in prion biology and structure.
    Moore RA; Faris R; Priola SA
    Expert Rev Proteomics; 2015 Apr; 12(2):171-84. PubMed ID: 25795148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases.
    Chen LN; Shi Q; Zhang BY; Zhang XM; Wang J; Xiao K; Lv Y; Sun J; Yang XD; Chen C; Zhou W; Han J; Dong XP
    Mol Neurobiol; 2016 Oct; 53(8):5079-96. PubMed ID: 26392294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide transcriptomics identifies an early preclinical signature of prion infection.
    Sorce S; Nuvolone M; Russo G; Chincisan A; Heinzer D; Avar M; Pfammatter M; Schwarz P; Delic M; Müller M; Hornemann S; Sanoudou D; Scheckel C; Aguzzi A
    PLoS Pathog; 2020 Jun; 16(6):e1008653. PubMed ID: 32598380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration in humans caused by prions.
    Prusiner SB
    West J Med; 1994 Sep; 161(3):264-72. PubMed ID: 7975565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of PRNP polymorphisms on human prion disease susceptibility: an update.
    Kobayashi A; Teruya K; Matsuura Y; Shirai T; Nakamura Y; Yamada M; Mizusawa H; Mohri S; Kitamoto T
    Acta Neuropathol; 2015 Aug; 130(2):159-70. PubMed ID: 26022925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics of Blood Pressure and Hypertension.
    Arnett DK; Claas SA
    Circ Res; 2018 May; 122(10):1409-1419. PubMed ID: 29748366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future.
    Parchi P; Strammiello R; Giese A; Kretzschmar H
    Acta Neuropathol; 2011 Jan; 121(1):91-112. PubMed ID: 21107851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of human prion diseases.
    Collinge J; Palmer MS
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):371-8. PubMed ID: 7913754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium review: Omics in dairy and animal science-Promise, potential, and pitfalls.
    Lippolis JD; Powell EJ; Reinhardt TA; Thacker TC; Casas E
    J Dairy Sci; 2019 May; 102(5):4741-4754. PubMed ID: 30268604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drosophila models of prionopathies: insight into prion protein function, transmission, and neurotoxicity.
    Fernandez-Funez P; Sanchez-Garcia J; Rincon-Limas DE
    Curr Opin Genet Dev; 2017 Jun; 44():141-148. PubMed ID: 28415023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the 20S proteasomes and prion-mediated neurodegenerations: potential therapeutic opportunities.
    Cecarini V; Bonfili L; Cuccioloni M; Mozzicafreddo M; Angeletti M; Eleuteri AM
    Apoptosis; 2010 Nov; 15(11):1322-35. PubMed ID: 20213200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroprotective role for microglia in prion diseases.
    Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
    J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.